Form D · Other Health Care
LumiraDx Ltd
London, X0 · CIK 0001685428
Offering snapshot reported Dec 15, 2020 · SEC filing
- Reported sold
- $164M Offering amount: $164M
- Investors reported
- 31 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 30, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 15, 2020 | Initial | $164,000,000 | No comparison | 31 | SEC filing |
| May 28, 2020 | Amendment | $150,000,000 | $97,450,000vs Apr 21, 2020 | 118 | SEC filing |
| Apr 21, 2020 | Amendment | $52,550,000 | No comparison | 20 | SEC filing |
| Apr 17, 2020 | Initial | $52,550,000 | No comparison | 20 | SEC filing |
| Apr 3, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 26, 2020 | Initial | $75,155,586 | No comparison | 171 | SEC filing |
| Sep 4, 2019 | Initial | $76,675,000 | No comparison | 188 | SEC filing |
| Jan 17, 2019 | Initial | $270,000,000 | No comparison | 256 | SEC filing |
| Dec 13, 2016 | Initial | $613,156 | No comparison | 6 | SEC filing |
| Oct 17, 2016 | Initial | $42,625,000 | No comparison | 2 | SEC filing |
| Oct 13, 2016 | Initial | $0 | No comparison | 34 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.23M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-383288
Amount sold shown in item 13 and number of investors in item 14 includes $105,500,000 from three non-US investors.
US Boston Capital Corp. receives an administrative fee and a placement fee based on amount sold. A portion of the fee was paid in preferred shares.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| U.S. Boston Capital Corporation | 5251 |
Source: Form D, filed Dec 15, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Veronique Ameye | Executive |
| Donald Berwick | Director |
| Troyen Brennan | Director |
| Troy Brennan | Director |
| Gerald Chan | Director |
| Lu Huang | Director |
| Lurene Joseph | Director |
| Bruce Keogh | Director |
| Dorian Le Blanc | Executive |
| Nigel Lindner | Executive |
| Jerry Mc Aleer | Director, Executive |
| Sumit Nagpal | Executive |
| George Neble | Director |
| Tom Quinlan | Executive |
| Peter Scheu | Executive |
| David Scott | Director, Executive |
| Amit Thakker | Director |
| Suresh Vazirani | Director |
| David Walton | Executive |
| Peter Welch | Executive |
| Ron Zwanziger | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3 More London Riverside
London, X0, SE1 2AQ
London, X0, SE1 2AQ